Kyma Medical Technologies
Remote Monitoring for Patients with Chronic Cardiac Diseases
Company Overview
Snapshot
Founded in February 2008 by Assaf Bernstein, Kyma Medical Technologies operated with 1–10 employees. The company raised $10,000,000 across one funding round from Ganot Capital before being acquired by Zoll in September 2015.
Business overview
Kyma Medical Technologies specializes in developing and commercializing monitoring solutions designed to enhance care for patients suffering from chronic cardiac illnesses. The company leverages proprietary RF-sensing technology to detect and track changes in fluid content within the body. Its flagship product, Kyma-Cor, is CE-marked for monitoring thoracic fluid contents, ECG, heart rate, respiratory rate, activity, and body posture. Kyma Medical Technologies serves the healthcare industry, focusing on digital healthcare, patient remote monitoring, and cardiology, with a presence in markets across Europe and the United States.
Strategic signal
In September 2015, Kyma Medical Technologies was acquired by Zoll for $35 million. This acquisition highlights the strategic value of Kyma's remote monitoring technology for chronic cardiac diseases and signals a consolidation trend in the digital health sector, where larger medical device companies are integrating innovative solutions to expand their patient care offerings.
Company Intelligence Q&A
- When was Kyma Medical Technologies founded?
- Kyma Medical Technologies was founded in February 2008.
- Who founded Kyma Medical Technologies?
- Kyma Medical Technologies was founded by Assaf Bernstein.
- What was a significant financial event for Kyma Medical Technologies?
- In October 2013, Kyma Medical Technologies raised $10,000,000 in a funding round from Ganot Capital.
- What was the outcome for Kyma Medical Technologies?
- Kyma Medical Technologies was acquired by Zoll in September 2015 for $35 million.
- What is the primary focus of Kyma Medical Technologies' technology?
- Kyma Medical Technologies develops monitoring solutions using proprietary RF-sensing technology to detect and monitor changes in fluid contents for patients with chronic cardiac illnesses.